• Low TNFα Levels Sustain Glioma Stem Cell Self-Renewal via Va

  2026-08-05

  This study demonstrates that low concentrations of tumor necrosis factor α (TNFα) in the glioma microenvironment promote the self-renewal of glioma stem cells (GSCs) through a Vasorin-mediated glycolytic pathway. The findings illuminate a mechanism underlying therapy resistance and poor prognosis in glioblastoma, highlighting new therapeutic targets for disrupting GSC maintenance.

• C/N-Selective Methyltransferase MaMT4 in Mulberry Alkaloid B

  2026-08-04

  The reference study identifies and characterizes MaMT4, a plant methyltransferase displaying unusual C/N-position selectivity in the biosynthesis of 1-deoxynojirimycin-type alkaloids in mulberry leaves. This work offers new mechanistic insights into plant methylation reactions, with implications for metabolic engineering of high-value bioactive compounds.

• Ceftolozane Sulfate in PK/PD and In Vitro Assays: Experiment

  2026-08-04

  Ceftolozane sulfate enables precise PK/PD and resistance studies targeting Pseudomonas aeruginosa, with robust stability against AmpC β-lactamases and high reproducibility in in vitro and animal models. APExBIO’s reagent quality elevates assay reliability and translational workflow flexibility, supporting both standard and extended infusion protocols in the study of multidrug-resistant pathogens.

• Sisomicin: Advanced Aminoglycoside Antibiotic Workflows in R

  2026-08-03

  Sisomicin empowers infection researchers with robust, reproducible protocols for both Gram-negative and Gram-positive bacterial models. Its distinct activity profile and protocol versatility make it the aminoglycoside of choice for high-demand antibacterial testing, especially where resistance and precise MIC determination are critical.

• QPRT Drives Breast Cancer Invasion via P2Y11-Linked Signalin

  2026-08-03

  This study reveals that quinolinate phosphoribosyltransferase (QPRT) enhances breast cancer cell invasiveness by promoting myosin light chain phosphorylation through purinergic signaling. Pharmacological inhibition of the P2Y11 receptor reverses these effects, highlighting QPRT and P2Y11 as potential therapeutic targets in breast cancer progression.

• Angiotensin (1-7): Protocols, Use-Cases, and Troubleshooting

  2026-08-02

  Angiotensin (1-7) (Asp-Arg-Val-Tyr-Ile-His-Pro) empowers researchers to dissect anti-fibrotic, anti-inflammatory, and neuroprotective mechanisms with high specificity across multiple organ models. This guide delivers practical protocols, optimization strategies, and actionable troubleshooting tips to maximize experimental clarity and reproducibility with APExBIO’s Angiotensin (1-7).

• Faropenem Sodium: Penem Antibiotic Workflows and Innovations

  2026-08-01

  Faropenem sodium stands out as a broad-spectrum penem antibiotic, excelling in both inhibition of bacterial cell wall synthesis and resilience against β-lactamase-mediated degradation. This article delivers actionable protocol guidance, advanced applications, and troubleshooting strategies to empower efficient and reproducible research with Faropenem sodium.

• Oral mSWI/SNF PROTAC Degrader and Resistance in Prostate Can

  2026-07-31

  This study introduces AU-24118, an orally bioavailable mSWI/SNF ATPase PROTAC degrader, and dissects the mechanisms of acquired resistance in prostate cancer. The findings reveal both genetic and transporter-based resistance pathways, providing actionable insight for overcoming therapeutic limitations in enhancer-driven cancers.

• G-1: Selective GPR30 Agonist for Advanced Cardiovascular and

  2026-07-31

  G-1, a highly selective GPR30 agonist, empowers rapid and reproducible insights into estrogen receptor signaling in both cardiovascular and oncology models. Its unmatched specificity, optimized protocols, and proven efficacy make it an essential tool for dissecting GPR30-mediated pathways where classical ER ligands fall short.

• Gamithromycin for Translational Respiratory Research: Mechan

  2026-07-30

  This thought-leadership article explores the mechanistic insights and strategic protocols for leveraging Gamithromycin (ML-1709460) in translational respiratory infection models. Grounded in recent combination therapy research and PK/PD optimization, it offers actionable guidance for researchers seeking to bridge bench results with in vivo efficacy—while highlighting APExBIO's leadership in quality and data-driven solutions.

• Levofloxacin: Strategic Insights from Antibacterial to Bone

  2026-07-30

  Explore the dual mechanistic and translational value of Levofloxacin, a synthetic fluoroquinolone antibiotic, for researchers bridging microbiology and bone metabolism. This article synthesizes recent resistance surveillance and advanced assay methodologies, offering actionable strategies for translational scientists navigating multidrug resistance and osteo-related complications.

• Ceftolozane/Tazobactam: Advances Against Resistant Gram-Nega

  2026-07-29

  The referenced study provides a comprehensive review of ceftolozane/tazobactam, a novel cephalosporin/β-lactamase inhibitor combination with notable efficacy against multidrug-resistant Gram-negative organisms. Its distinct mechanism and pharmacokinetic profile advance options for complicated intraabdominal and urinary tract infections, with practical implications for antimicrobial resistance research.

• Acetylcholine Chloride in Gut-Brain Axis Assays: Protocols a

  2026-07-29

  Explore how Acetylcholine Chloride advances gut-brain axis and cholinergic signaling research. This article uniquely dissects protocol parameters, mechanistic insights, and translational assay choices for acetylcholine neurotransmitter studies.

• Prestained Protein Marker (Triple Color): SDS-PAGE to Wester

  2026-07-28

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) delivers accurate molecular weight standards for SDS-PAGE and Western blot protein size verification. Its tri-color, EDTA-free formulation optimizes compatibility with phosphoprotein and fluorescent imaging workflows, while eliminating the need for additional sample preparation. APExBIO provides validated protocols for reproducibility and transfer efficiency.

• 3-Deazaadenosine: Epitranscriptomic Control and Antiviral Pr

  2026-07-28

  Explore how 3-Deazaadenosine, a potent S-adenosylhomocysteine hydrolase inhibitor, enables advanced modulation of methylation and viral pathways. This article uniquely integrates the latest epitranscriptomic insights with practical assay guidance for preclinical antiviral and fibrotic disease research.

452 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page